Immunologic Non-Responder
Showing 1 - 25 of >10,000
HIV-1-infection Trial (Fostemsavir 600 MG [Rukobia])
Recruiting
- HIV-1-infection
- Fostemsavir 600 MG [Rukobia]
-
Orlando, FloridaOrlando Immunology Center
Sep 20, 2022
AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)
Recruiting
- AIDS Virus
- Disorder of Immune Reconstitution
- normal saline
- Mesenchymal stem cells
-
Jinan, Shandong, ChinaShandong Public Health Clinical Center
May 14, 2023
Heart Failure Trial in Shatin (Electrical Activation Mapping Guided Cardiac resynchronization therapy)
Recruiting
- Heart Failure
- Electrical Activation Mapping Guided Cardiac resynchronization therapy
-
Shatin, Hong KongThe Chinese University of Hong Kong
Sep 22, 2022
Non Small Cell Lung Cancer Trial in Pittsburgh (Fecal Microbiota Transplant (FMT), Pembrolizumab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Fecal Microbiota Transplant (FMT)
- Pembrolizumab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Dec 20, 2022
Preoperative Radiotherapy for Non-responder Patients After
Completed
- Breast Neoplasms
- +3 more
- Radiotherapy
-
Istanbul, TurkeyIstanbul Breast Society
Mar 1, 2022
Erectile Dysfunction Trial in Sohag (hyperbaric oxygen therapy within hyperbaric oxygen therapy chamber.)
Active, not recruiting
- Erectile Dysfunction
- hyperbaric oxygen therapy within hyperbaric oxygen therapy chamber.
-
Sohag, EgyptFaculty of medicine sohag university
Jun 26, 2022
Social Anxiety Disorder Trial (Group CBT for Social Anxiety Disorder, Sertraline, Individual CBT for Social Anxiety Disorder)
Not yet recruiting
- Social Anxiety Disorder
- Group CBT for Social Anxiety Disorder
- +2 more
- (no location specified)
Jan 20, 2023
Post Induction Hypotension Trial in Cairo (Ringer acetate)
Completed
- Post Induction Hypotension
- Ringer acetate
-
Cairo, EgyptKasr Al Ainy
Jul 14, 2022
HIV-Infected Individuals Trial in Baltimore (DD HST-NEETs)
Recruiting
- HIV-Infected Individuals
- DD HST-NEETs
-
Baltimore, MarylandJohns Hopkins University(Jhu)
Mar 2, 2022
NSCLC Stage I Trial in Baltimore (Post-SABR Biopsy)
Recruiting
- Non-small Cell Lung Cancer Stage I
- Post-SABR Biopsy
-
Baltimore, MarylandBayview Medical Center
Nov 23, 2021
![](/image/sponsor/irccs_national_neurological_institute_"c_mondino"_foundation)
Chronic Migraine, Headache Trial in Pavia (ketogenic diet)
Recruiting
- Chronic Migraine, Headache
- ketogenic diet
-
Pavia, ItalyHeadache Science Center
Mar 28, 2022
Natural History of Noncirrhotic Portal Hypertension
Recruiting
- Cystic Fibrosis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 27, 2022
The Liver in World Trade Center Health Program General Responder
Completed
- Steatosis of Liver
- NASH - Nonalcoholic Steatohepatitis
- Fibroscan of Liver
- Low-dose non-contrast CT
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 9, 2021
Obesity, Overweight Trial in New Haven (Behavioral Weight Loss (BWL), Early Responder: BWL continued, Early Non-responder: BWL
Recruiting
- Obesity, Overweight
- Behavioral Weight Loss (BWL)
- +2 more
-
New Haven, ConnecticutYale University
Oct 14, 2021
Heart Failure, Cardiac Resynchronization Therapy Trial in Neuilly-sur-Seine, Montmorency, Poitiers (Device programming of CRT
Terminated
- Heart Failure
- Cardiac Resynchronization Therapy
- Device programming of CRT pacemaker or defibrillator
-
Neuilly-sur-Seine, Ile De France, France
- +2 more
Jan 25, 2021
Portal Hypertension in Patients With CVID (CVID-pHT)
Recruiting
- Non-Cirrhotic Portal Hypertension
- Common Variable Immunodeficiency
- Ultrasound including color doppler ultrasound
-
Freiburg, GermanyUniversity Medical Center Freiburg, Department of Medicine II
Nov 21, 2023
Inflammation, Blood Clotting and Blood Vessel Function in
Enrolling by invitation
- Inflammation
- Pathologic Processes
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
HIV Trial in Washington (HST-NEETs)
Active, not recruiting
- HIV Infections
- HST-NEETs
-
Washington, District of Columbia
- +2 more
Feb 22, 2022
Primary Immune Deficiency Disorder, Periodontitis Trial in London (Oral hygiene advice, non surgical periodontal treatment)
Completed
- Primary Immune Deficiency Disorder
- Periodontitis
- Oral hygiene advice, non surgical periodontal treatment
-
London, Greater London, United Kingdom
- +1 more
Nov 10, 2022
Primary Immunodeficiency Diseases (PID) Trial (TAK-771)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- (no location specified)
Aug 22, 2022
Lung Cancer Metastatic Trial in Durham (Nivolumab, Ipilimumab, Evolocumab)
Recruiting
- Lung Cancer Metastatic
- Nivolumab
- +2 more
-
Durham, North CarolinaDuke Univ. Medical Center
May 16, 2022
HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against
Not yet recruiting
- HPV 16+ Recurrent or Metastatic Cancer
- CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
- Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
- (no location specified)
Jun 27, 2022
Immunologic Checkpoint Inhibitors in NSCLC
Not yet recruiting
- Non Small Cell Lung Cancer
- Immune checkpoint inhibitor
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Feb 23, 2021
Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,
Recruiting
- Severe Sickle Cell Disease
- +5 more
- RIC regimen
- GVHD prophylaxis regimen
-
New Haven, Connecticut
- +1 more
Feb 4, 2022
Malignant Tumors of Mesothelial and Soft Tissue, Human Immunodeficiency Virus Trial in Houston (behavioral, device, procedure)
Completed
- Malignant Neoplasms of Mesothelial and Soft Tissue
- Human Immunodeficiency Virus
- Screening Interview
- +5 more
-
Houston, TexasBering Omega/Houston Area Community Services
Feb 10, 2022